BR112012011224A2 - teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico - Google Patents

teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico

Info

Publication number
BR112012011224A2
BR112012011224A2 BR112012011224A BR112012011224A BR112012011224A2 BR 112012011224 A2 BR112012011224 A2 BR 112012011224A2 BR 112012011224 A BR112012011224 A BR 112012011224A BR 112012011224 A BR112012011224 A BR 112012011224A BR 112012011224 A2 BR112012011224 A2 BR 112012011224A2
Authority
BR
Brazil
Prior art keywords
theobromine
opioid
antitussive
therapeutic use
agent combined
Prior art date
Application number
BR112012011224A
Other languages
English (en)
Portuguese (pt)
Inventor
Robin Mark Bannister
John Brew
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of BR112012011224A2 publication Critical patent/BR112012011224A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR112012011224A 2009-11-13 2010-11-12 teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico BR112012011224A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
PCT/GB2010/051896 WO2011058374A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
BR112012011224A2 true BR112012011224A2 (pt) 2017-03-01

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011224A BR112012011224A2 (pt) 2009-11-13 2010-11-12 teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico

Country Status (19)

Country Link
EP (1) EP2498776A1 (https=)
JP (2) JP2013510842A (https=)
CN (1) CN102740853B (https=)
AU (1) AU2010317668C1 (https=)
BR (1) BR112012011224A2 (https=)
CA (1) CA2780704C (https=)
CO (1) CO6551745A2 (https=)
EC (2) ECSP12011893A (https=)
GB (1) GB0919893D0 (https=)
IL (1) IL219769A0 (https=)
MX (1) MX2012005538A (https=)
NZ (1) NZ599957A (https=)
PE (1) PE20121472A1 (https=)
PH (1) PH12012500955A1 (https=)
RU (1) RU2587329C2 (https=)
SG (1) SG10201407496SA (https=)
UA (1) UA105940C2 (https=)
WO (1) WO2011058374A1 (https=)
ZA (1) ZA201204247B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339054B1 (de) * 1987-10-08 1994-07-06 Andor Bilas Stoffgemisch zur stabilisierung der stoffwechsel-lage
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
EP1465634B1 (en) * 2001-12-12 2014-10-22 The Government of the United States of America, as represented by the Secretary Department of Health and Human Services Methods for using adenosine receptor inhibitors to enhance immune response and inflammation
AU2004216550B2 (en) * 2003-02-28 2010-06-03 Ym Biosciences Inc. Opioid delivery system
CN1593451A (zh) * 2003-09-12 2005-03-16 杨喜鸿 促进男性勃起的外用药物
CA2594987A1 (en) * 2004-12-14 2006-06-22 Shionogi & Co., Ltd. Therapeutic agent for constipation
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물

Also Published As

Publication number Publication date
JP2013510842A (ja) 2013-03-28
RU2012124063A (ru) 2013-12-20
SG10201407496SA (en) 2015-02-27
AU2010317668B2 (en) 2015-01-22
UA105940C2 (uk) 2014-07-10
GB0919893D0 (en) 2009-12-30
IL219769A0 (en) 2012-07-31
AU2010317668C1 (en) 2016-02-11
ZA201204247B (en) 2013-02-27
PE20121472A1 (es) 2012-11-30
AU2010317668A1 (en) 2012-06-07
CA2780704A1 (en) 2011-05-19
ECSP12011892A (es) 2012-09-28
EP2498776A1 (en) 2012-09-19
CN102740853B (zh) 2015-04-08
PH12012500955A1 (en) 2013-01-07
RU2587329C2 (ru) 2016-06-20
ECSP12011893A (es) 2012-10-30
WO2011058374A1 (en) 2011-05-19
JP2016041748A (ja) 2016-03-31
NZ599957A (en) 2014-05-30
CA2780704C (en) 2018-07-17
CN102740853A (zh) 2012-10-17
MX2012005538A (es) 2012-09-28
CO6551745A2 (es) 2012-10-31

Similar Documents

Publication Publication Date Title
BR112015025711A8 (pt) uso de ibrutinibe e coposição farmacêutica compreendendo ibrutinibe e um agente anticâncer
BR112012014159A8 (pt) combinações terapêuticas de teobromina e um anti-histamínico
BRPI0714712B8 (pt) dispositivo para administração de fármaco
MX2009010066A (es) Composiciones y metodos para la ablacion especifica de la evasion mutacional de terapias especificas para cancer.
CL2007000876A1 (es) Uso de un antagonista del factor de crecimiento endotelial vascular (vegf) en combinacion con un segundo agente que comprende un agente reductor de celula mieloide para tratar un tumor resistente en un sujeto; y metodo de diagnostico del tumor.
CL2008002381A1 (es) Oligonucleotido inmunoestimulador; composicion farmaceutica que lo comprende; y su uso para tratar un trastorno o afeccion en un sujeto, incluyendo cancer.
GT201300320A (es) Terapia de combinación que comprende un inhibidor de cdk4/6 y un inhibidor de pi3k para el uso en el tratamiento de cáncer.
BRPI1011572A2 (pt) Glico-oligossacarídeos compreendendo ligações glicosídias (alfa1-4) e (alfa1-6), seu uso, e métodos para o seu fornecimento
BR112012011227A2 (pt) teobromina e agente combinado com outro antitussígeno não opióide e seu uso terapêutico
MX361778B (es) Composiciones farmaceuticas y metodos de tratamiento.
BR112012022243A8 (pt) Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
PA8631801A1 (es) Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
BR112012011224A2 (pt) teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico
BR112013017953A2 (pt) Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora
PH12013500392A1 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
BR112015019021A2 (pt) método e sistema para a geração de uma saída de configuração
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
DK2050435T3 (da) Hostepræparat
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.
CL2011000252A1 (es) Uso de estriol para preparar un medicamento util en la prevencion y/o el tratamiento de atrofia urogenital en mujeres.
ECSP12011969A (es) Combinaciones terapéuticas de teobromina y una antihistamina
廖勇 Syntactic Structure of Interrogative Sentences and Relative Clauses in English--An over-view of Wh-movement
TH147571A (th) การบำบัดร่วมที่ประกอบรวมด้วยสารยับยั้ง CDK4/6 (CDK4/6 inhibitor) และสารยับยั้ง PI3K สำหรับใช้ในการรักษาของมะเร็ง
UA101837C2 (ru) Инъекционное средство с иммуностимулирующими и общеукрепляющими свойствами на основе меда
CL2011000095A1 (es) Uso de una forma de dosificacion que comprende un descongestionante y un corticoesteroide para preparar un medicamento util para tratar o aliviar uno o mas sintomas de una condicion alergica o inflamatoria; forma de dosificacion.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2493 DE 16/10/2018.